Form 8-K - Current report:
SEC Accession No. 0000950170-24-089940
Filing Date
2024-08-02
Accepted
2024-08-02 16:05:10
Documents
11
Period of Report
2024-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20240801.htm   iXBRL 8-K 37281
  Complete submission text file 0000950170-24-089940.txt   146599

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20240801.xsd EX-101.SCH 23882
13 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240801_htm.xml XML 4534
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 241170916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)